Why Dr. Reddy's Laboratories Ltd ADR (RDY) Stock Is Rising
As of 2026-07-17, Dr. Reddy's Laboratories Ltd ADR (RDY) has a next-year EPS growth estimate of 25.25%.
Why RDY Stock Is Rising
- ·Current-Year Growth: Projected at -3.86%, supporting the forward estimate revision.
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- EPS growth next year
- 25.25%
- EPS growth this year
- -3.86%
- EPS next quarter (est)
- $0.09
- Last price
- $12.60
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-07-17 | 25.25% | -3.86% | $0.09 | $12.60 |
| 2026-07-16 | 25.75% | -4.15% | $0.09 | $12.70 |
| 2026-07-15 | 25.75% | -4.13% | $0.09 | $12.77 |
| 2026-07-14 | 25.75% | -4.13% | $0.09 | $12.84 |
| 2026-07-13 | 25.75% | -4.13% | $0.09 | $12.92 |
| 2026-07-12 | 25.57% | -3.97% | $0.09 | $13.19 |
Screen Performance
Aggregate stats across all 1864 tickers our top-EPS-revision screen has flagged over the past 107 days.
- Median return since detection
- +2.5%
- % of tickers in the green
- 55%
- Median return on winners
- +20.8%
- Large revisions captured
- 1048
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
Why did Dr. Reddy's Laboratories Ltd ADR (RDY) stock go up recently?▾
Dr. Reddy's Laboratories Ltd ADR (RDY) stock has risen following an analyst upgrade of its next-year EPS growth estimate on 2026-07-12. EPS estimate upgrades are among the strongest leading indicators of stock outperformance.
What is Dr. Reddy's Laboratories Ltd ADR's next-year EPS growth estimate?▾
As of 2026-07-17, Dr. Reddy's Laboratories Ltd ADR (RDY) has a next-year EPS growth estimate of 25.25%, based on analyst consensus.
When was the latest EPS estimate revision for RDY?▾
The most recent revision occurred on 2026-07-17, when analysts adjusted the next-year EPS growth estimate from 25.75% to 25.25%.
What sector and industry does Dr. Reddy's Laboratories Ltd ADR belong to?▾
Dr. Reddy's Laboratories Ltd ADR operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. RDY appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Dr. Reddy's Laboratories Ltd ADR (RDY) appears here because it was detected by our daily top-EPS-revision-performer screen.